Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Ncardia is a fully integrated Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) focused on induced Pluripotent Stem Cell (iPSC) technology. They specialize in the development, manufacturing, and commercialization of iPSC-derived cells (e.g., cardiomyocytes, neurons) and assays for drug discovery, toxicology, and cell therapy development. Ncardia aims to provide its partners with robust, scalable, and translatable human cellular models and services to de-risk and accelerate therapeutic programs from discovery to clinic.
The Leuven headquarters serves as the central hub for Ncardia's corporate governance, strategic planning, finance, and global operational management. It likely also supports R&D and business development activities.
Situated within Bio-Incubator 1, the headquarters benefits from modern laboratory and office facilities designed for life science companies, fostering collaboration and access to a rich biotech ecosystem.
Ncardia's work culture is expected to be science-driven, innovative, and collaborative, emphasizing quality, precision, and teamwork to advance iPSC technology and meet client needs in a dynamic industry.
The strategic location in Leuven provides Ncardia with access to top talent, research institutions, and a network of biotech companies, enhancing its innovation capabilities and European presence.
Ncardia operates globally with key facilities in Europe (Belgium, Netherlands, Germany) and North America (USA). This network supports worldwide pharmaceutical and biotech companies, and academic institutions by providing iPSC-derived cell products, custom assay development, disease modeling, and GMP-ready manufacturing services for drug discovery, safety pharmacology, and cell therapy development.
Gaston Geenslaan 1, Bio-Incubator 1
Leuven
Flemish Brabant
Belgium
Address: Zernikedreef 12, BioPartner 5 Building, 2333 CL Leiden, The Netherlands
Serves as a key European center for iPSC production, R&D, and commercial activities, supporting clients across the continent.
Address: Nattermannallee 1, 50829 Cologne, Germany
Contributes significantly to Ncardia's European production capacity and scientific expertise in specialized iPSC-derived cell types and services.
Address: 2400 Main Street Extension, Suite 100, Sayreville, New Jersey 08872, USA
Drives Ncardia's growth and service delivery in North America, catering to pharmaceutical, biotech, and academic partners in the region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Ncardia' leadership includes:
Ncardia has been backed by several prominent investors over the years, including:
Ncardia significantly strengthened its executive leadership team over the past 12 months with strategic appointments in finance, science, and commerce to drive its next phase of growth and innovation in the iPSC field. No major executive departures were publicly announced during this period.
Discover the tools Ncardia uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Ncardia commonly uses the [first].[last]@ncardia.com email format for its employees. This is a standard professional email structure in many life science and technology companies.
[first].[last]@ncardia.com
Format
john.doe@ncardia.com
Example
85%
Success rate
Ncardia Website • April 18, 2024
Ncardia announced its participation in the International Society for Stem Cell Research (ISSCR) 2024 Annual Meeting in Hamburg. The company will present its cutting-edge advancements in iPSC technology, including new cell models and applications relevant for drug discovery and cell therapy....more
PR Newswire • November 28, 2023
Ncardia announced the appointment of Jorg Rühle as its new Chief Financial Officer. Mr. Rühle brings over 20 years of experience in finance and strategy within the life sciences and technology sectors to support Ncardia's continued growth and strategic objectives....more
Ncardia Website • October 17, 2023
Ncardia strengthened its leadership team with the appointment of Shushma Rekhi, PhD, as Chief Scientific Officer. Dr. Rekhi will lead Ncardia's scientific vision, research and development programs, and innovation pipeline for iPSC-based solutions....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Ncardia, are just a search away.